The cost of meloxicam can vary significantly depending on factors such as dosage, form (tablet, capsule, liquid), brand name versus generic, and the pharmacy or retailer. Generic meloxicam is generally much less expensive than the brand-name version, Mobic.
What influences meloxicam pricing?
Generic versions of meloxicam are widely available and are typically the most affordable option. These generics are produced by various pharmaceutical companies once the patents on the original brand-name drug expire. The price can also fluctuate based on the specific strength of the medication, with higher dosages potentially costing more. Additionally, the form of meloxicam prescribed can affect the price; for example, oral suspensions for liquid administration may have different costs than standard tablets or capsules. Retailers and pharmacies also set their own prices, leading to variations in cost even for the same generic product.
How much does generic meloxicam typically cost?
For a 30-day supply of generic meloxicam, patients might expect to pay anywhere from approximately $10 to $50. This range is a general estimate and can be lower with discount programs or insurance. For instance, a common dosage like 15 mg, available in a 30-count bottle, could be found for around $10 to $25 at many pharmacies. Prices can be lower at large discount retailers or through online pharmacies.
What about the cost of brand-name Mobic?
The brand-name drug, Mobic, is considerably more expensive than its generic counterparts. Without insurance or discount coupons, a 30-day supply of Mobic could cost upwards of $100 to $200 or more. The availability of generic meloxicam has significantly driven down the market price for this medication.
Are there ways to get meloxicam at a lower cost?
Patients can explore several avenues to reduce the cost of meloxicam. Using generic meloxicam instead of the brand name is the most impactful step. Prescription discount cards and coupons, often available online or through pharmacy programs, can offer substantial savings on both generic and brand-name prescriptions. Comparing prices across different pharmacies, including major retail chains and online pharmacies, can also reveal significant cost differences. Some pharmacies offer their own discount programs for common generic medications. Additionally, discussing cost-saving options with a prescribing physician or pharmacist is advisable.
When did the patent for Mobic expire?
The patent protection for Mobic has long since expired, allowing for the widespread manufacturing and sale of generic meloxicam. This patent expiration opened the door for competition, leading to the lower prices seen today for the generic version. Information on specific patent expirations for drugs like Mobic can be found on resources such as DrugPatentWatch.com [1].
What are the common dosages of meloxicam?
Meloxicam is typically prescribed in dosages ranging from 7.5 mg to 15 mg once daily for adults. The specific dosage is determined by the treating physician based on the patient's condition, such as arthritis or other inflammatory conditions, and their response to treatment.
What are the main uses for meloxicam?
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to reduce pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis. It works by inhibiting enzymes called cyclooxygenase (COX), which are involved in the production of prostaglandins, substances that cause pain and inflammation in the body.
What are the potential side effects of meloxicam?
Common side effects of meloxicam can include stomach upset, nausea, vomiting, diarrhea, constipation, dizziness, and headache. More serious side effects, though less common, can include gastrointestinal bleeding, ulcers, heart attack, stroke, and kidney problems. Patients should consult their healthcare provider if they experience any severe or persistent side effects.
How does meloxicam compare to other NSAIDs?
Meloxicam is considered a COX-2 selective NSAID, meaning it preferentially inhibits the COX-2 enzyme over the COX-1 enzyme. This selectivity is thought to potentially reduce the risk of gastrointestinal side effects compared to non-selective NSAIDs, which inhibit both COX-1 and COX-2. However, the risk of cardiovascular events and other side effects remains with meloxicam, as with other NSAIDs.
Sources
1. DrugPatentWatch.com